Page last updated: 2024-09-05

bifeprunox and lassbio-581

bifeprunox has been researched along with lassbio-581 in 1 studies

Compound Research Comparison

Studies (bifeprunox)	Trials (bifeprunox)	Recent Studies (post-2010) (bifeprunox)	Studies (lassbio-581)	Trials (lassbio-581)	Recent Studies (post-2010) (lassbio-581)
30	1	12	6	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonio, CB; Barreiro, EJ; Fraga, CA; Grazziottin, LR; Menegatti, R; Neves, G; Noël, F; Rates, SM; Vieira, RO	1

Other Studies

1 other study(ies) available for bifeprunox and lassbio-581

Article	Year
Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors. Bioorganic & medicinal chemistry, 2010, Mar-01, Volume: 18, Issue:5 Topics: Administration, Oral; Animals; Antipsychotic Agents; Cell Line; Humans; Ligands; Male; Mice; Piperazines; Pyrazoles; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia	2010

Article

Year

Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.

Bioorganic & medicinal chemistry, 2010, Mar-01, Volume: 18, Issue:5

Topics: Administration, Oral; Animals; Antipsychotic Agents; Cell Line; Humans; Ligands; Male; Mice; Piperazines; Pyrazoles; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia

2010